Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	693.47	559.93	331.15	279.05	230.04	265.88
Cash & Short-Term Investments	693.47	559.93	331.15	279.05	230.04	265.88
Cash Growth	30.68%	69.09%	18.67%	21.30%	-13.48%	3687.41%
Accounts Receivable	3.49	2.74	0.14	-	18	-
Other Receivables	2.07	1.71	0.95	0.84	0.2	0.22
Receivables	5.57	4.46	1.09	0.84	18.2	0.22
Prepaid Expenses	4.16	1.73	1.64	2.28	1.38	0.97
Other Current Assets	16.12	22.77	13.42	3.6	1.82	0.66
Total Current Assets	719.31	588.89	347.29	285.77	251.44	267.73
Property, Plant & Equipment	22.03	23.49	19.47	17.57	2.4	1.6
Other Long-Term Assets	1.45	3.51	3.26	3.45	1.41	0.12
Total Assets	742.78	615.89	370.03	306.78	255.25	269.44
Accounts Payable	2.3	4.6	5.45	3.34	3.65	2.15
Accrued Expenses	14.96	20.45	17.25	12	7.03	4.21
Current Portion of Leases	2.32	1.98	1.01	0.46	0.86	0.42
Current Income Taxes Payable	4.15	-	-	-	0.11	0.19
Current Unearned Revenue	0.16	-	-	-	-	-
Other Current Liabilities	0.21	0.42	0.67	0.75	0.2	0.22
Total Current Liabilities	24.09	27.45	24.37	16.55	11.85	7.18
Long-Term Leases	15.11	16.88	13.44	12.81	0.23	0.48
Other Long-Term Liabilities	-	-	-	-	-	0.06
Total Liabilities	39.2	44.33	37.81	29.36	12.08	7.72
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,162	1,140	713.64	505.86	366.93	326.73
Retained Earnings	-458.3	-568.78	-381.43	-228.43	-123.76	-65.01
Total Common Equity	703.58	571.55	332.21	277.42	243.17	261.72
Shareholders' Equity	703.58	571.55	332.21	277.42	243.17	261.72
Total Liabilities & Equity	742.78	615.89	370.03	306.78	255.25	269.44
Total Debt	17.43	18.86	14.44	13.27	1.09	0.9
Net Cash (Debt)	676.04	541.07	316.7	265.78	228.95	264.98
Net Cash Growth	32.20%	70.84%	19.16%	16.09%	-13.60%	33483.90%
Net Cash Per Share	16.49	14.45	10.75	10.53	9.81	17.09
Filing Date Shares Outstanding	30.47	40.56	35.98	28.54	24	23.27
Total Common Shares Outstanding	40.63	40.55	31.84	27.54	23.97	23.19
Working Capital	695.22	561.44	322.92	269.22	239.59	260.54
Book Value Per Share	17.32	14.09	10.43	10.07	10.14	11.28
Tangible Book Value	703.58	571.55	332.21	277.42	243.17	261.72
Tangible Book Value Per Share	17.32	14.09	10.43	10.07	10.14	11.28
Machinery	-	7.19	5.85	2.97	1.92	1.19
Leasehold Improvements	-	-	-	0.21	0.26	0.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q